JANX
Janux Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:20:29 PM EST
10.27USD-0.388%(-0.04)318,346
Pre-marketNov 19, 2026 9:26:30 AM EST
10.33USD+0.194%(+0.02)
JANX Financials
In Q3 FY 2026 (ended ), Janux Therapeutics, Inc. Common Stock (JANX) reported revenue of $9.29M, net income of −$21.57M, operating cash flow of −$25.18M, and assets of $983.66M (filed ).
Loading financial statements…